![Investors see Harris winning the election, Evercore's survey shows](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEK6O0WM_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.660 | 6.660 | 0.000 |
Stocks | 93.870 | 93.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.827 | 18.836 |
Price to Book | 3.751 | 2.977 |
Price to Sales | 4.698 | 2.621 |
Price to Cash Flow | 9.757 | 10.596 |
Dividend Yield | 0.135 | 2.292 |
5 Years Earnings Growth | 9.808 | 11.956 |
Number of long holdings: 122
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Cytokinetics Inc | US23282W6057 | 2.63 | 57.32 | +1.90% | |
Karuna Therapeutics Inc | US48576A1007 | 1.66 | - | - | |
ACADIA | US0042251084 | 1.61 | 15.94 | +1.66% | |
Biohaven Pharma | VGG1110E1079 | 1.39 | 41.73 | +4.43% | |
Amicus | US03152W1099 | 1.35 | 11.760 | +0.51% | |
Blueprint Medicines Corp | US09627Y1091 | 1.34 | 94.55 | +1.11% | |
Arrowhead Pharma | US04280A1007 | 1.34 | 24.78 | +1.68% | |
BridgeBio Pharma | US10806X1028 | 1.34 | 25.31 | +1.69% | |
Moderna | US60770K1079 | 1.33 | 82.44 | +1.73% | |
Ultragenyx | US90400D1081 | 1.27 | 56.75 | +0.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Hang Seng China Enterprise Cash | 270.02M | 7.02 | -11.10 | -4.43 | ||
E Hang Seng China Enterpr ETFUSD TT | 270.02M | 7.02 | -11.10 | -4.43 | ||
E Fd S&P Info Tech Idx QDII LOF USD | 168.52M | 21.15 | 14.25 | - | ||
E Fund Global Medical Industry USD | 140.23M | -17.15 | -28.64 | - | ||
E Fd S&P 500 Idx QDII LOFUSD | 79.84M | 14.46 | 7.63 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review